# Hypofractionation Proton Beam Therapy With Concurrent Treatment of Prostate and Pelvic Nodes for Prostate Cancer

> **NCT02874014** · PHASE2 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 56 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **RADIATION:** Hypofractionation Proton beam therapy with Concurrent Treatment of the Prostate and Pelvic Nodes

## Key facts

- **NCT ID:** NCT02874014
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07-25
- **Primary completion:** 2021-02-08
- **Final completion:** 2025-04-30
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2025-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02874014

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02874014, "Hypofractionation Proton Beam Therapy With Concurrent Treatment of Prostate and Pelvic Nodes for Prostate Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02874014. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*